ABBV-295
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie · Phase 2 · Recruiting · Enrollment 360
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| ABBV-295 Arm 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 5 | Obesity or overweight | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 6 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |